XB010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XB010, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of XB010 in Subjects With Solid Tumors [Phase 1]